Viewing Study NCT02860767


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-03-01 @ 6:01 AM
Study NCT ID: NCT02860767
Status: COMPLETED
Last Update Posted: 2017-10-11
First Post: 2016-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dosing of Antibiotics During Reimplantation of Infected Knee and Hip Prostheses
Sponsor: Tourcoing Hospital
Organization:

Study Overview

Official Title: Dosing of Antibiotics (Serum and Periprosthetic Tissues) During Reimplantation of Infected Knee and Hip Prostheses
Status: COMPLETED
Status Verified Date: 2016-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DOSOS
Brief Summary: The purpose of the study is to evaluate the concentrations of antibiotics used as empirical treatment in serum and periprosthetic tissues during reimplantation of infected hip and knee prostheses
Detailed Description: The purpose of the study is to evaluate the concentrations of antibiotics (daptomycin, vancomycin, cefotaxime, ceftriaxone, cefepime) in serum and periprosthetic tissues(bone and synovial joint) used as empirical treatment during reimplantation of infected hip and knee prostheses (1-stage or 2-stage management).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: